Abbott (ABT), Reckitt Unit Defeat Infant-formula Sickness Claims - Bloomberg
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Join SI Premium – FREE
Abbott (NYSE: ABT), Reckitt Unit Defeat Infant-formula Sickness Claims - Bloomberg
- Abbott, Reckitt Trial Victory Is First In Infant-formula Cases
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's Muse AI to counter China models with subscribers, not ads, Alexandr Wang says - Nikkei
- FDA approves first once-weekly insulin for type 2 diabetes mellitus in pediatric patients
- Howard Hughes Holdings CFO to depart in March 2027
Create E-mail Alert Related Categories
Corporate News, Hot Corp. News, LitigationRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
